Pancreas Transplant Rejection
📧 Sign up to get email alerts when something new happens for Pancreas Transplant Rejection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2025-06-15Clinical Trial Update: TACKLE-IT Trial - Treat Acute T Cell Rejection With Evidence and Confidence in Kidney Transplant Recipients [Phase 3]
Phase 3 TACKLE-IT trial investigates treatment for acute T cell rejection in kidney transplant recipients. The study also references a pancr…
-
FDA approval · 2024-08-13FDA Approved: MYCOPHENOLATE MOFETIL — Supplemental Application (Accord Healthcare Inc.)
FDA approves Accord Healthcare's supplemental application for generic Mycophenolate mofetil. The approval supports continued use for prevent…
-
FDA approval · 2021-08-11FDA Approved: MYCOPHENOLIC ACID — Supplemental Application (Apotex Corp)
FDA approved a supplemental application for mycophenolic acid submitted by Apotex Corp.
-
FDA approval · 2020-12-03FDA Approved: TACROLIMUS — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for tacrolimus submitted by Mylan Pharmaceuticals Inc.
-
FDA approval · 2020-11-12FDA Approved: TACROLIMUS — Original Application (Ascend Laboratories, LLC)
FDA approved Ascend Laboratories' tacrolimus as a new generic to prevent organ transplant rejection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2019-09-17FDA Approved: TACROLIMUS — Supplemental Application (Sandoz Inc.)
The FDA approved a supplemental application for tacrolimus from Sandoz Inc., resulting in changes to the approved product, such as labeling …
-
FDA approval · 2019-06-11FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for Prograf (tacrolimus) filed by Astellas Pharma US, Inc. The action updates the labeling to re…
-
CLINICAL_TRIALS trial_result · 2019-04-17Clinical Trial Update: Vascularised Sentinel Skin Flaps to Detect Rejection in Pancreas Transplantation [Phase 1, Phase 2]
A two-phase clinical trial evaluating vascularised sentinel skin flaps to detect rejection in pancreas transplantation, with preliminary inf…
-
CLINICAL_TRIALS trial_result · 2018-06-06Clinical Trial Update: Study of Alemtuzumab Versus Anti-thymocyte Globulin to Help Prevent Rejection in Kidney and Pancreas Transplantation [Phase 4]
Phase 4 trial comparing alemtuzumab to anti-thymocyte globulin for prevention of graft rejection in kidney and pancreas transplantation; com…
-
FDA approval · 2018-05-24FDA Approved: PROGRAF — Supplemental Application (Astellas Pharma US, Inc.)
The FDA approved a supplemental application for PROGRAF (tacrolimus) submitted by Astellas Pharma US, Inc.
-
FDA approval · 2016-06-22FDA Approved: ENVARSUS XR — Supplemental Application (Veloxis Pharmaceuticals, Inc)
The FDA approved a supplemental application for ENVARSUS XR (tacrolimus) submitted by Veloxis Pharmaceuticals, Inc., adding/updating its ind…